concept

hallucinogens

Also known as: hallucinogen use, psychedelics, hallucinogen

synthesized from dimensions

Hallucinogens, frequently referred to as psychedelics or serotonergic hallucinogens, are a class of psychoactive substances characterized by their capacity to profoundly alter consciousness, perceptual processes, and sensory modalities. These compounds, which are often alkaloids derived from botanical or fungal sources—though they can also be synthesized—induce non-ordinary states of consciousness (H-ASC). Key subjective effects include synesthesia, distortions in the perception of time, space, and self, and the potential for "peak" or mystical experiences. The specific nature of these experiences is heavily mediated by the user's "set and setting"—their internal expectations and the external environment in which the substance is administered.

Pharmacologically, these substances have been extensively reviewed by researchers such as David E. Nichols, who has distinguished them from other classes like entactogens. Modern neuroscience employs the "REBUS and the anarchic brain" model to explain their action, suggesting that psychedelics function by relaxing high-level priors and increasing neural entropy. Neuroimaging studies, such as those by Erritzoe et al. (2011), have examined serotonin transporter and 2A receptor binding, while other research indicates that these substances shift brain connectivity by strengthening between-network links and modulating neuroplasticity [bd35f040-9d1d-4a3e-ae81-a3f7309078a1, f24f35aa-38e1-48db-be7f-00e884bbdcc3].

The therapeutic potential of hallucinogens is a significant area of contemporary research, with investigations spanning mental health disorders and post-comatose disorders of consciousness [1f56f946-c1a8-4d87-b2ea-6c604b8062f8, 1c3c2c31-0437-4759-9259-b06f2ee602d9]. Studies from institutions like the Johns Hopkins Center for Psychedelic and Consciousness Research have explored their use in psychotherapy, noting potential benefits such as reduced recidivism among offenders [beb743cf-e744-42a7-91d2-21f2d7b02935]. While small-scale trials have demonstrated a favorable safety profile, researchers emphasize the necessity of larger studies and caution against use in individuals predisposed to psychosis [c6519f91-24ab-402c-9a06-b6c69d67eb95].

Beyond clinical applications, hallucinogens serve as critical tools for investigating the "easy problems of consciousness," such as the relationship between subjective experience and brain activity [42593b01-60e8-4c72-a6ba-0b31fb0569b7]. However, there is ongoing debate regarding their utility in addressing the "hard problem" of consciousness, with some scholars arguing they offer limited insight into this fundamental mystery [cc85698e-6196-49fd-acd7-47a95cb30d3e]. Researchers also utilize neurophenomenological approaches to compare these states with other practices like meditation and hypnosis [c6f1bf5b-02a4-419e-bb06-5a3088f97eb3].

Historically and anthropologically, the human use of hallucinogens is deeply rooted in religious and healing practices dating back to the dawn of civilization [25, 36, 51]. Evolutionary perspectives suggest that hominin populations may have faced selection pressures from these environmental chemicals, influencing the development of specific hepatic enzymes [54]. Today, the study of these substances remains a multidisciplinary endeavor, bridging neuroscience, evolutionary biology, clinical psychology, and cultural history to understand how these molecules interact with the human mind to produce profound, often life-altering, shifts in perspective.

Model Perspectives (3)
openrouter/google/gemini-3.1-flash-lite-preview definitive 100% confidence
Hallucinogens, also referred to as psychedelics, are psychoactive substances defined by their capacity to profoundly alter consciousness, perceptual processes, and sensory modalities [6, 44]. These substances are primarily alkaloids, a group of complex organic molecules found in various plants and fungi [37, 40]. While modern science can synthesize these compounds, their origins are largely botanical [37]. Physiologically and psychologically, hallucinogens induce dreamlike states, synesthesia, and distortions in the perception of time, space, and self [4, 7, 9]. The experience is often described as meaningful or momentous, though effects can range from experiences of bliss to paranoia or psychosis [31, 34]. According to research cited by Springer, the specific outcome of use is heavily influenced by the user's expectations and the environment in which the substance is administered [5]. Research into these substances spans multiple disciplines. In neuroscience, hallucinogens are utilized to investigate the mechanisms of perception and consciousness [21, 41]. Medically, there is renewed interest in their therapeutic potential for mental health, driven by observations that 'peak experiences' may promote healing and well-being [3, 17, 49]. This therapeutic investigation dates back to the 1960s [47]. Anthropological and evolutionary perspectives highlight that the human use of these substances is deeply rooted in history. Ancient cultures have utilized plant and fungal hallucinogens for religious and healing practices since the dawn of civilization [25, 36, 51]. Evolutionary evidence suggests that hominin populations faced selection pressures from these environmental chemicals, leading to the development of specific hepatic enzymes [54]. Furthermore, researchers like David E. Nichols have contributed to the classification of these substances, distinguishing them from other classes such as entactogens [8, 13, 53].
openrouter/x-ai/grok-4.1-fast definitive 92% confidence
Hallucinogens, also termed psychedelics or serotonergic hallucinogens, are powerful psychoactive substances that profoundly alter perception, mood, and cognitive processes, as defined by researchers in PMC publications. Psychedelics as serotonergic hallucinogens David E. Nichols has extensively reviewed their pharmacology, authoring key works like 'Hallucinogens' in Pharmacology & Therapeutics (2004) and Pharmacological Reviews (2016), published by Elsevier. Nichols' 2004 hallucinogens review Nichols' 2016 hallucinogens overview They induce altered states of consciousness (H-ASC), with Adolf Dittrich's 1985 empirical research identifying etiology-independent structures across hallucinogens and other methods, though authors in Semantic Scholar perspectives call for more detailed studies. Dittrich's ASC structures research Brain mechanisms include the 'REBUS and the anarchic brain' model proposed by Carhart-Harris and Friston (2019) in Pharmacological Reviews, explaining psychedelic action via relaxed priors and increased entropy. REBUS model by Carhart-Harris Nour et al. (2016) validated the Ego-Dissolution Inventory for psychedelics in Frontiers in Human Neuroscience. Ego-dissolution inventory validation Therapeutic potential spans mental disorders, per MDPI claims, and post-comatose disorders of consciousness (DoC), with brain-complexity enhancement suggested in PMC and a 2019 Neuroscience of Consciousness paper. Psychedelics for mental disorders Psychedelics for DoC treatment Johns Hopkins Center researchers like Roland R. Griffiths emphasize subjective effects, mystical experiences, and psychotherapy integration. Effects include delayed REM sleep from daytime dosing (Psychedelic Review), wake-promotion in animals, enhanced familiarity in episodic memory, and shifted brain connectivity strengthening between-network links (Oxford University Press). Psychedelics delay REM sleep Between-network connectivity changes Safety is good in small trials but requires larger studies (Taylor & Francis). Historical uses trace to plant origins (Richard Evans Schultes in Science) and archaeological Datura evidence (Robinson et al., Frontiers). Psychedelics probe 'easy problems of consciousness' like subjectivity-brain links (David B. Yaden et al., Oxford University Press). Easy problems of consciousness
openrouter/x-ai/grok-4.1-fast 88% confidence
Hallucinogens, often interchangeably termed psychedelics in research, are substances whose pharmacology and effects are comprehensively reviewed by David Nichols in his 2004 article 'Hallucinogens' and 2016 review 'Psychedelics'. Nichols' 2004 hallucinogens review Nichols 2016 psychedelics overview Nichols 2004 review reprint. These compounds induce non-ordinary states of consciousness, explored neurophenomenologically alongside hypnosis and meditation by Timmermann et al. in Trends in Cognitive Sciences (2023) and compared in neural correlates by Moujaes et al. (2023). neurophenomenological psychedelics study neural correlates comparison. A 2021 review distinguishes uses of 'consciousness' in psychedelic research, while David B. Yaden et al. argue they offer little insight into the hard problem of consciousness. psychedelics consciousness review hard problem argument. Therapeutic potential includes reduced recidivism among offenders, per MacLean, Johnson, and Griffiths from Johns Hopkins Center for Psychedelic and Consciousness Research (2014), and modulation of neuroplasticity. recidivism reduction study neuroplasticity modulation. Rodent models separate hallucinations from therapeutic effects, and they act as discriminative stimuli in animals like LSD, phenethylamines, and tryptamines (J.C. Winter, 2008). rodent hallucinations study animal discriminative stimuli. Brain imaging by Erritzoe et al. (2011) examined serotonin transporter and 2A receptor binding in MDMA and hallucinogen users, with Alnagger et al. noting greater brain perturbation under psychedelics. serotonin imaging study psychedelic brain perturbation. Acute effects depend on 'set and setting,' and they influence social cognition (Preller and Vollenweider, 2019) and gene expression. set and setting effects social cognition modulation. Cross-cultural perspectives are covered by Dobkin de Rios (1984) and Quirce et al. (2010), with cautions from Raquel Consul et al. to limit use in psychosis-prone individuals. cross-cultural book use limitation perspective. Michael Pollan's book discusses their science on consciousness and therapy, and online discourse uses conceptual metaphors. Pollan psychedelics book conceptual metaphors study.

Facts (115)

Sources
Psychedelics and Consciousness: Distinctions, Demarcations, and ... ouci.dntb.gov.ua David B Yaden, Matthew W Johnson, Roland R Griffiths, Manoj K Doss, Albert Garcia-Romeu, Sandeep Nayak, Natalie Gukasyan, Brian N Mathur, Frederick S Barrett · Oxford University Press 15 facts
referenceRichard Evans Schultes authored 'Hallucinogens of plant origin', published in Science, volume 163, page 245.
referenceNour validated the Ego-Dissolution Inventory (EDI) in the context of ego-dissolution and psychedelics, published in Frontiers in Human Neuroscience (Volume 10).
claimDavid B Yaden et al. state that psychedelics are relevant to the 'easy problems of consciousness,' which involve the relationships between subjectivity, brain function, and behavior.
claimSedatives (alcohol, zolpidem, triazolam), dissociatives (ketamine, dextromethorphan), psychedelics (psilocybin, MDMA), stimulants (dextroamphetamine, dextromethamphetamine), and cannabinoids (THC) each have idiosyncratic effects on episodic memory, differentially impairing certain mnemonic processes while sparing or facilitating others.
claimRoland Griffiths conducted a survey comparing naturally occurring 'God encounter experiences' with those occasioned by classic psychedelics including psilocybin, LSD, ayahuasca, or DMT.
claimThe study of drug effects on episodic memory provides a framework for understanding unique subjective phenomena, such as blackouts from sedatives or déjà vu from psychedelics.
referenceNichols discussed psychedelics as medicines in an emerging new paradigm, published in Clinical Pharmacology & Therapeutics (Volume 101, page 209).
referenceNichols authored a review on psychedelics published in Pharmacological Reviews (Volume 68, page 264).
claimThere are no significant between-drug differences in the selectivity of psychedelics for the 5-HT2A, 5-HT2C, or D2 receptors, relative to the 5-HT1A receptor.
referenceNayak authored 'Psychedelics and psychotherapy,' published in Pharmacopsychiatry.
claimPsychedelics administered at encoding tend to enhance familiarity and do not impact metamemory.
claimPsychedelics significantly strengthen between-network functional connectivity while significantly diminishing within-network functional connectivity.
perspectiveDavid B Yaden et al. argue that psychedelics are unlikely to provide information relevant to the 'hard problem of consciousness,' which involves explaining how first-person experience emerges.
referenceMichael Pollan authored the book 'How to change your mind: what the new science of psychedelics teaches us about consciousness, dying, addiction, depression, and transcendence'.
claimThe acute subjective effects of psychedelics are influenced by the expectations and surroundings of the user, a phenomenon referred to as "set and setting."
Psychedelics, Sociality, and Human Evolution frontiersin.org Frontiers 14 facts
claimThe initial consumption of a plant for medicinal purposes likely led to the discovery of its use as a hallucinogen, given the overlap between medicinal and hallucinogenic uses.
claimD. W. Robinson, K. Brown, M. McMenemy, L. Dennany, M. J. Baker, P. Allan, et al. confirmed the ingestion of hallucinogens at Pinwheel Cave, California, through the discovery of Datura quids in 2020.
referenceDe Gregorio et al. (2018) examined the mechanism of action and potential therapeutic applications of LSD, psilocybin, and other classic hallucinogens in mood disorders, published in Progress in Brain Research.
referenceMichael J. Winkelman and M. Hoffman authored the chapter 'Hallucinogens and entheogens' in the 2015 book 'Vocabulary for the Study of Religion, Vol. 2', published by Koninklijke Brill.
referenceThe review article 'Clinical applications of hallucinogens: a review', published in 2016 in Experimental and Clinical Psychopharmacology by A. Garcia-Romeu, B. Kersgaard, and P. H. Addy, summarizes the clinical uses of hallucinogenic substances.
referenceDavid E. Nichols published 'Hallucinogens' in the journal Pharmacological Reviews in 2016, which provides an overview of psychedelics.
referencePennacchio, Jefferson, and Havens (2010) authored 'Uses and Abuses of Plant-Derived Smoke: Its Ethnobotany as Hallucinogen, Perfume, Incense, and Medicine', which covers the ethnobotanical uses of plant smoke.
referenceThe book 'Flesh of the Gods: The Ritual Use Of Hallucinogens', edited by P. T. Furst and published in 1990 by Waveland, covers the ritualistic use of hallucinogenic substances.
claimHuman ancestors constructed a niche that adaptively integrated mind-altering substances, including hallucinogens, stimulants, and narcotics, into their culture.
referenceDe Gregorio et al. (2021a) reviewed preclinical and clinical studies on the use of hallucinogens, specifically LSD, psilocybin, MDMA, and ketamine, in mental health, published in the Journal of Neuroscience.
referenceMichael J. Harner edited 'Hallucinogens and Shamanism', published by Oxford University Press in 1973.
referencePreller and Vollenweider (2019) published 'Modulation of social cognition via hallucinogens and entactogens' in Frontiers in Psychiatry, reviewing how these substances affect social processing.
claimEvolutionary evidence regarding human hepatic enzymes suggests that hominin populations faced significant selection pressures from frequently encountered environmental chemicals, including fungal and vegetal secondary metabolites that function as stimulants, narcotics, and hallucinogens (Sullivan and Hagen, 2002; Sullivan et al., 2008).
referenceQuirce et al. (2010) published 'Los alucinógenos: su historia, antropología, química y farmacología' (The hallucinogens: Their history, anthropology, chemistry, and pharmacology) in the journal Psicogente, providing a multidisciplinary overview of hallucinogens.
Hallucinogenic Plants and Their Use in Traditional Societies culturalsurvival.org Cultural Survival Feb 19, 2010 9 facts
claimThe effects of hallucinogens on the human mind include a dreamlike state marked by dramatic alterations in the sphere of experience, perception of reality, consciousness of self, and changes in the perception of space and time.
procedureHallucinogens may be absorbed by the human body through various methods, including smoking, snuffing, swallowing fresh or dried plant material, drinking decoctions and infusions, absorbing directly through the skin, placing in wounds, or administering as enemas.
claimThe distinction between a hallucinogen, a medicine, and a poison is often determined by dosage.
claimA hallucinogen is defined as any chemical substance that distorts the senses and produces hallucinations, which are perceptions or experiences that depart from ordinary reality.
claimHallucinogens invariably induce a series of visual hallucinations, often in kaleidoscopic movement, and usually in indescribably brilliant and rich colours, frequently accompanied by auditory and other hallucinations - tactile, olfactory, and temporal.
claimThe pharmacological activity of hallucinogens is caused by a relatively small number of types of chemical compounds, and while modern chemistry can duplicate or synthesize these substances, virtually all hallucinogens originate in plants.
claimMost hallucinogens are alkaloids, a family of approximately 5,000 complex organic molecules that also account for the biological activity of most toxic and medicinal plants.
claimThe use of pharmacologically active plants is rooted in culture, as evidenced by the fact that Amerindian societies explored their forests for hallucinogens while African societies did not.
claimIn the Amazon, indigenous groups use hallucinogens to divine the future, track enemy movements, ensure the fidelity of women, and diagnose or treat diseases.
Classification Schemes of Altered States of Consciousness - ORBi orbi.uliege.be ORBi 8 facts
referenceAdolf Dittrich published empirical research in 1985 titled 'Atiologie-unabhängige Strukturen veränderter Wachbewusstseinszustände', which examines etiology-independent structures of altered states of consciousness, including hallucinogens, sensory deprivation, hypnagogic states, hypnotic procedures, and sensory overload.
referenceMontgomery, Amaya, and Schmidt conducted a study comparing the effects of flicker light stimulation and psychedelics on the emotional response to music, published in Frontiers in Psychology in 2024.
referenceS. Rankaduwa and Adrian M. Owen published 'Psychedelics, entropic brain theory, and the taxonomy of conscious states: a summary of debates and perspectives' in 2023, which summarizes current debates regarding psychedelics and conscious states.
referenceMillière, Carhart-Harris, Roseman, Trautwein, and Berkovich-Ohana explored the relationship between psychedelics, meditation, and self-consciousness in a 2018 article published in Frontiers in Psychology.
referenceThe article 'The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects' by D. B. Yaden and R. R. Griffiths was published in ACS Pharmacology & Translational Science in 2021.
claimBarrett and Griffiths (2018) examined the phenomenology and neural correlates of mystical experiences induced by classic hallucinogens.
referenceTimmermann et al. published a neurophenomenological approach to non-ordinary states of consciousness, specifically covering hypnosis, meditation, and psychedelics, in Trends in Cognitive Sciences in 2023.
referenceMoujaes et al. (2023) compare the neural correlates of consciousness across different states, specifically examining psychedelics, hypnosis, and meditation.
Hallucinogens | Springer Nature Link link.springer.com Springer 8 facts
claimAt lower doses, hallucinogens produce alterations and distortions in sensory processing, including synesthesias where senses mix, such as perceiving music as colorful kaleidoscopic patterns.
claimHallucinogens are drugs characterized by their ability to produce alterations in perceptual processes and profound changes in consciousness involving all sensory modalities.
claimHallucinogens produce changes in mood and affect, and can alter the perception of time, space, and self in ways that typically occur only during dreaming or religious exaltation.
referenceThe entry 'Hallucinogens' was authored by D.E. Nichols and published in the Encyclopedia of Psychopharmacology in 2013 by Springer, Berlin, Heidelberg.
claimAlterations in consciousness caused by hallucinogens can range from feelings of bliss and oneness with the universe to fear, paranoia, and psychotic reactions.
claimHallucinogens increase the intensity and lability of affective responses and engender a sense of portentousness, where the experience is perceived as highly meaningful and momentous.
referenceThe article 'Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines' was authored by J.C. Winter and published in Psychopharmacology (Berl) in 2008, volume 203, issue 2, pages 251–263.
referenceNichols DE (2004) published a review on hallucinogens.
Published Studies — Johns Hopkins Center for Psychedelic and ... hopkinspsychedelic.org Johns Hopkins Center for Psychedelic and Consciousness Research 7 facts
claimDextromethorphan, which acts as an NMDA antagonist, produces effects similar to classic hallucinogens when administered in high doses.
referenceD. B. Yaden, S. M. Nayak, and R. R. Griffiths authored a paper titled 'Understanding therapeutically relevant acute subjective effects of psychedelics' published in Nature Reviews Psychology in 2024.
referenceA 2018 review by Johnson, Hendricks, Barrett, and Griffiths provided an integrative analysis of classic psychedelics covering epidemiology, therapeutics, mystical experience, and brain network function.
referenceE. Hokanson, J. Gukasyan, N. Pittenger, C. Kelmendi, B. Ross, S. Glick, G., and O’Donnell, K. C. authored a paper titled 'The pharmacology of hallucinogens' published in Principles of Addiction Medicine in 2024.
referenceTupper, Wood, Yensen, and Johnson authored a chapter on hallucinogens and club drugs in The American Psychiatric Publishing Textbook of Substance Abuse in 2015.
claimSalvinorin A is a kappa opioid agonist hallucinogen found in the plant Salvia divinorum.
referenceMacLean, Johnson, and Griffiths published a study in the Journal of Psychopharmacology in 2014 finding that hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision.
The Mechanisms of Psychedelic Visionary Experiences - Frontiers frontiersin.org Frontiers Sep 27, 2017 5 facts
referenceFranz Vollenweider published 'Recent advances and concepts in the search for biological correlates of hallucinogen-induced altered states of consciousness' in the Heffter Review of Psychedelic Research in 1998 (Heffter Rev. Psychedel. Res. 1, 21–32).
referenceFranz Vollenweider published 'Brain mechanisms of hallucinogens and entactogens' in Dialogues in Clinical Neuroscience in 2001 (Dialogues Clin. Neurosci. 3, 265–279).
referenceCarhart-Harris, Kaelen, and Nutt (2014) authored an article titled 'How do hallucinogens work on the brain?' published in The Psychologist.
referenceDavid Nichols' 2004 review article, 'Hallucinogens', provides an overview of the pharmacology of hallucinogenic substances.
referenceDavid Nichols' 2016 review article, 'Psychedelics', provides a comprehensive overview of the pharmacology and effects of psychedelic substances.
Altered States of Consciousness, Psychedelics - Academia.edu academia.edu Academia.edu 5 facts
claimPsychedelics are recognized for their therapeutic potential and their ability to re-orient beliefs, though the potential for these substances to induce false or maladaptive beliefs remains under-considered in experimental work.
perspectiveIn the book 'Philosophy of Psychedelics', Chris Letheby argues that psychedelics and knowledge are compatible, suggesting that while psychedelics may induce new mental states, some of these states can constitute knowledge.
claimResearch on the subjective effects of psychedelics is experiencing a resurgence, with a specific focus on 'mystical-type experiences,' though the field continues to rely on limited models and biased sources originating from the 1960s.
claimScientific interest in the mode of action and therapeutic potential of psychedelics has increased since the 1990s.
claimA corpus-based cognitive study aims to identify the conceptual metaphors used to discuss psychedelics in online texts published by organizations that popularize knowledge about psychedelic substances.
Neuroimaging in psychedelic drug development: past, present, and ... nature.com Nature Sep 27, 2023 4 facts
referenceCarhart-Harris and Friston (2019) proposed the 'REBUS and the anarchic brain' model in Pharmacological Reviews as a unified model for the brain action of psychedelics.
referenceNour MM, Evans L, Nutt D, Carhart-Harris RL authored 'Ego-dissolution and psychedelics: Validation of the ego-dissolution inventory (EDI)', published in Frontiers in Human Neuroscience in 2016, volume 10, page 269.
referenceErritzoe et al. (2011) conducted in vivo imaging of cerebral serotonin transporter and serotonin 2A receptor binding in users of 3,4-methylenedioxymethamphetamine (MDMA or ‘Ecstasy’) and other hallucinogens.
referenceThe effects of hallucinogens on gene expression are detailed in the book 'Behavioral Neurobiology of Psychedelic Drugs', published by Springer in 2018.
Conflicting States of Consciousness: Exploring Psilocin and Sleep psychedelicreview.com Psychedelic Review May 25, 2022 4 facts
claimDay-time administration of psychedelics in humans delays the time to the first REM sleep period.
claimThomas posits that understanding the interaction between psychedelics and sleep may help determine the optimal timing of a psychedelic experience within the sleep-wake cycle, such as whether morning or evening administration provides more lasting benefits.
claimPsychedelics have acutely wake-promoting effects in animals.
claimPsychedelics are thought to modulate neuroplasticity, which may contribute to their therapeutic efficacy.
Altered states of consciousness – Knowledge and References taylorandfrancis.com Raquel Consul, Flávia Lucas, Maria Graça Campos · Taylor & Francis 3 facts
perspectiveLarger clinical trials are required to better determine the frequency of clinically relevant adverse events and to optimize safety protocols for psychedelics, given the good tolerability and safety reported in small trials.
claimMost contemporary clinical trials of psychedelics have excluded participants with active suicidal ideation, with the exception of a small placebo-controlled randomized controlled trial of ayahuasca that demonstrated a larger reduction in suicidality compared to placebo.
perspectiveThe use of psychedelics should be limited to clinical trials for individuals with a personal history of psychosis, mania, or hypomania until the risks are better characterized.
Effects of psychedelics on neurogenesis and broader neuroplasticity link.springer.com Springer Dec 19, 2024 3 facts
claimDavid E. Nichols identified a new therapeutic class of drugs called entactogens in 1986, distinguishing them from MDMA, MBDB, and classic hallucinogens based on their mechanism of action.
claimThe hallucinogen N,N-dimethyltryptamine (DMT) functions as an endogenous sigma-1 receptor regulator.
accountResearch with hallucinogens began in the 1960s when leading psychiatrists observed therapeutic potential in the compounds now referred to as psychedelics, as noted by Osmond (1957) and Vollenweider and Kometer (2010).
the consumption of psychoactive plants in ancient global and ... academia.edu Academia.edu 2 facts
referenceNichols DE authored 'Hallucinogens', published in Pharmacology & Therapeutics in 2004.
referenceDobkin de Rios M published 'Hallucinogens: Cross-Cultural Perspectives' in 1984 through the University of New Mexico Press in Albuquerque, NM.
Altered States of Consciousness . A Comparative Review of the ... semanticscholar.org Semantic Scholar 2 facts
perspectiveThe authors of 'Altered States of Consciousness . A Comparative Review of the ...' assert that more detailed scientific research is required to understand altered states of consciousness induced by hallucinogens (H-ASC).
claimAltered states of consciousness induced by hallucinogens (H-ASC) are considered a vaguely understood phenomenon in the paper 'Altered States of Consciousness . A Comparative Review of the ...'.
Unknown source 2 facts
referenceThe academic paper titled 'Altered states of consciousness: Review of experimental data obtained with psychedelics' was published in the journal Pharmacological Reviews, volume 71, issue 3, pages 316–344.
claimA virtual clinical trial is modeling the effects of psychedelics on patients in a coma.
Ancient Roots of Today's Emerging Renaissance in ... link.springer.com Springer 2 facts
quoteThe effects of hallucinogens are heavily dependent on the expectations of the user and the environment in which the use takes place.
referenceAlbert Garcia-Romeu, Brennan Kersgaard, and Peter H. Addy published a review on the clinical applications of hallucinogens in Experimental and Clinical Psychopharmacology in 2016.
[PDF] Psychedelics and novel non-hallucinogenic analogs for ... - UC Davis escholarship.org eScholarship 2 facts
claimThe researchers of the study 'Psychedelics and novel non-hallucinogenic analogs for ...' investigated whether hallucinations are necessary to achieve the therapeutic effects of psychedelics or if hallucinations and therapeutic effects are dissociable phenomena.
procedureThe researchers of the study 'Psychedelics and novel non-hallucinogenic analogs for ...' utilized rodent behavioral models to study the relationship between hallucinations and the therapeutic effects of psychedelics.
History and Current Status of Psychedelics and Entactogens ... - NCBI ncbi.nlm.nih.gov Stroud C, Posey Norris SM, Matney C · National Academies Press 2 facts
claimAlternative terms proposed for psychedelic drugs include 'hallucinogen,' 'entheogen' (accessing the divine within), 'allucinari' (mind journeying, mind wandering, mind traveling), 'psychotomimetic,' 'mysticomimetic,' and 'phantasticant.'
claimCharles Grob categorized hallucinogens into classic and non-classic types.
Psychedelics and Consciousness: Distinctions, Demarcations ... - PMC pmc.ncbi.nlm.nih.gov PMC 2 facts
claimPsychedelics bear on multiple "easy problems of consciousness."
claimPsychedelics relate to multiple "easy problems of consciousness," which are defined as the relations between subjectivity, brain function, and behavior.
The Montreal model: an integrative biomedical-psychedelic ... frontiersin.org Frontiers in Psychiatry 2 facts
referenceMajić, Schmidt, and Gallinat published 'Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?' in the Journal of Psychopharmacology (2015), investigating the relationship between peak experiences and therapeutic outcomes.
claimSedatives, dissociatives, psychedelics, stimulants, and cannabinoids have unique effects on episodic memory, specifically impacting recollection, familiarity, and metamemory.
Psychedelics and Consciousness: Distinctions, Demarcations, and ... blossomanalysis.com Blossom Analysis 2 facts
claimPsychedelics are useful tools for investigating the 'easy problems of consciousness,' which involve the relations between subjectivity, brain function, and behavior, including perception, attention, and selfhood.
referenceThe 2021 review 'Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities' examines how the term 'consciousness' is used in psychedelic research and how theories of consciousness are operationalized to explain the effects of psychedelics.
A virtual clinical trial of psychedelics to treat patients with disorders ... eurekalert.org EurekAlert! Nov 24, 2025 2 facts
claimThe simulated treatment effect of psychedelics was greater in patients with minimally conscious state (MCS) compared to patients with unresponsive wakefulness syndrome (UWS) in the study 'A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness'.
claimAlnagger et al. showed that under the influence of psychedelics, perturbation induces a greater response in the brain than in healthy individuals without the drug.
Medicinal plants meet modern biodiversity science - OUCI ouci.dntb.gov.ua Charles C. Davis, Patrick Choisy · Elsevier BV 1 fact
claimRenewed interest in psychedelics as therapeutic tools is driven by early observations regarding the role of peak experiences in promoting well-being and healing.
Psychedelics and disorders of consciousness: the current landscape ... pmc.ncbi.nlm.nih.gov PMC Jun 15, 2024 1 fact
claimBrain-complexity enhancing psychedelics have been suggested as a potential treatment for individuals suffering from post-comatose disorders of consciousness (DoC).
Psychedelic-Induced Neural Plasticity: A Comprehensive Review ... mdpi.com MDPI 1 fact
claimPsychedelics are increasingly recognized as a promising and innovative treatment strategy for several mental disorders.
[PDF] Proceedings of the Second Curing Coma Campaign NIH Symposium dspace.mit.edu MIT DSpace 1 fact
referenceThe paper titled 'Psychedelics as a treatment for disorders of consciousness' was published in the journal Neuroscience of Consciousness in 2019 (Volume 2019, Issue 1, Article niz003).
Psychedelics - PMC pmc.ncbi.nlm.nih.gov PMC 1 fact
claimPsychedelics, also known as serotonergic hallucinogens, are powerful psychoactive substances that alter perception and mood and affect numerous cognitive processes.
The development of consciousness from an evolutionary perspective academia.edu Academia.edu 1 fact
claimResearch on hallucinogens demonstrates that mental processes can transcend linguistic limitations.
Hallucinogen - an overview | ScienceDirect Topics sciencedirect.com ScienceDirect 1 fact
claimHallucinogens have played a critical role in neuroscience by elucidating the molecular and neural mechanisms underlying perception, cognition, and consciousness.
The Resurgence of Hallucinogen Drugs in Clinical Research sciencedirect.com ScienceDirect 1 fact
claimAncient cultures have utilized hallucinogens derived from plants and fungi for religious and healing practices since the dawn of civilization.
#17 — ”Global Workspace Theory… - Consciousness and the Brain podcasts.apple.com Apple Podcasts Nov 22, 2021 1 fact
claimIlian Daskalov is a senior undergraduate student at the University of California, Irvine, studying Cognitive Science, with research interests in sleep, psychedelics, and artificial intelligence.
Hallucinogens - ScienceDirect.com sciencedirect.com ScienceDirect 1 fact
claimHallucinogens, also known as psychedelics, are psychoactive substances that powerfully alter perception, mood, and a host of cognitive processes.